Literature DB >> 31630287

Defining Sexual Risk in the Era of Biomedical HIV Prevention: Implications for HIV Research and Practice.

Keith J Horvath1,2, Sara Lammert3, Aldona Martinka3, Darin Erickson3.   

Abstract

Advancing HIV behavioral science and its integration with recent biomedical prevention strategies-treatment as prevention and pre-exposure prophylaxis (PrEP)-is complicated because traditional definitions of sexual risk (condomless anal sex [CAS] or CAS with a serodiscordant partner) may not suffice given the success of biomedical prevention in the absence of condoms. To better understand how to define and understand risk in the era of biomedical HIV prevention, we assessed correlates of four different definitions of high-risk sexual behavior among a sample of 401 adult HIV-positive MSM (57% African American) residing in the New York City area: (1) a traditional model of risk defined as CAS with an HIV-negative or unknown serostatus partner; (2) a definition that considered participant viral load (VL); (3) a definition that considered partner PrEP use; and (4) a definition that considered participant HIV VL and partner PrEP use. Among participants reporting anal sex (n = 281) with a man in the past 3 months, 42% were considered high risk under Definition 1, 6% under Definition 2, 25% under Definition 3, and 2% under Definition 4. Correlates of risk varied across definitions. For example, while education was the strongest predictor of high-risk sexual behavior in Definitions 1 and 2, alcohol use and enacted stigma were the strongest predictors in the model that only accounted for partner PrEP use (Definition 3). These findings have implications for whom to reach for intervention efforts, the difficulty in meeting recruitment goals, and the types of interventions that should be used.

Entities:  

Keywords:  Condomless sex; HIV risk; Men who have sex with men; PrEP; Viral load

Mesh:

Year:  2019        PMID: 31630287      PMCID: PMC7018580          DOI: 10.1007/s10508-019-01499-8

Source DB:  PubMed          Journal:  Arch Sex Behav        ISSN: 0004-0002


  28 in total

1.  Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-01-28       Impact factor: 17.586

2.  The MOS social support survey.

Authors:  C D Sherbourne; A L Stewart
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

Review 3.  New developments in biological measures of drug prevalence.

Authors:  E J Cone
Journal:  NIDA Res Monogr       Date:  1997

4.  Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.

Authors:  Benjamin R Bavinton; Angie N Pinto; Nittaya Phanuphak; Beatriz Grinsztejn; Garrett P Prestage; Iryna B Zablotska-Manos; Fengyi Jin; Christopher K Fairley; Richard Moore; Norman Roth; Mark Bloch; Catherine Pell; Anna M McNulty; David Baker; Jennifer Hoy; Ban Kiem Tee; David J Templeton; David A Cooper; Sean Emery; Anthony Kelleher; Andrew E Grulich
Journal:  Lancet HIV       Date:  2018-07-17       Impact factor: 12.767

5.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

6.  Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: A randomized controlled trial.

Authors:  Christopher W Kahler; David W Pantalone; Nadine R Mastroleo; Tao Liu; Gerald Bove; Bharat Ramratnam; Peter M Monti; Kenneth H Mayer
Journal:  J Consult Clin Psychol       Date:  2018-08

7.  Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal.

Authors:  Carrie E Lyons; Sosthenes Ketende; Daouda Diouf; Fatou M Drame; Benjamin Liestman; Karleen Coly; Cheikh Ndour; Gnilane Turpin; Souleymane Mboup; Karim Diop; Coumba Toure-Kane; Delivette Castor; Nafissatou Leye-Diouf; Stefan Baral
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

8.  HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel.

Authors:  Jeanne M Marrazzo; Carlos del Rio; David R Holtgrave; Myron S Cohen; Seth C Kalichman; Kenneth H Mayer; Julio S G Montaner; Darrell P Wheeler; Robert M Grant; Beatriz Grinsztejn; N Kumarasamy; Steven Shoptaw; Rochelle P Walensky; Francois Dabis; Jeremy Sugarman; Constance A Benson
Journal:  JAMA       Date:  2014 Jul 23-30       Impact factor: 56.272

9.  Reconsidering "Unprotected" and HIV Risk in the Twenty-First Century.

Authors:  Brian C Kelly
Journal:  Front Immunol       Date:  2016-06-08       Impact factor: 7.561

10.  Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.

Authors:  Alison J Rodger; Valentina Cambiano; Tina Bruun; Pietro Vernazza; Simon Collins; Olaf Degen; Giulio Maria Corbelli; Vicente Estrada; Anna Maria Geretti; Apostolos Beloukas; Dorthe Raben; Pep Coll; Andrea Antinori; Nneka Nwokolo; Armin Rieger; Jan M Prins; Anders Blaxhult; Rainer Weber; Arne Van Eeden; Norbert H Brockmeyer; Amanda Clarke; Jorge Del Romero Guerrero; Francois Raffi; Johannes R Bogner; Gilles Wandeler; Jan Gerstoft; Felix Gutiérrez; Kees Brinkman; Maria Kitchen; Lars Ostergaard; Agathe Leon; Matti Ristola; Heiko Jessen; Hans-Jürgen Stellbrink; Andrew N Phillips; Jens Lundgren
Journal:  Lancet       Date:  2019-05-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.